Runx2 trans-activation mediated by the Msx2-interacting nuclear target requires homeodomain interacting protein kinase-3

Molecular Endocrinology

Volumn 24, Issue 7, 2010, Pages 1478-1497

  Sierra, Oscar L ^a   Towler, Dwight A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIMETHYLAMINO 4,5,6,7 TETRABROMO 1H BENZIMIDAZOLE; ALANINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; ASPARTIC ACID; CASEIN KINASE II; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HOMEODOMAIN INTERACTING PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; PHOSPHOTRANSFERASE INHIBITOR; PROLINE DIRECTED PROTEIN KINASE; PROTEIN KINASE; SERINE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; THREONINE; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; 2-DIMETHYLAMINO-4,5,6,7-TETRABROMO-1H-BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; COMPLEMENTARY RNA; NUCLEAR PROTEIN; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; SPEN PROTEIN, MOUSE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IN VITRO STUDY; MOLECULAR RECOGNITION; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OC GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CONFOCAL MICROSCOPY; GENE SILENCING; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION;

MAMMALIA;

ANIMALS; BENZIMIDAZOLES; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE SILENCING; IMMUNOPRECIPITATION; MICE; MICROSCOPY, CONFOCAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PROLINE-DIRECTED PROTEIN KINASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RNA, ANTISENSE; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION;

EID: 77954827971     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0029     Document Type: Article

References (61)

1. Jilka RL 2007 Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434-1446
2. Marie PJ, Coffin JD, Hurley MM 2005 FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J Cell Biochem 96:888-896
3. Cancedda R, Bianchi G, Derubeis A, Quarto R 2003 Cell therapy for bone disease: a review of current status. Stem Cells 21:610-619 (Pubitemid 37444117)
4. Franceschi RT, Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454
5. Khosla S, Westendorf JJ, Oursler MJ 2008 Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118:421-428
6. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM 2000 Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093
7. Hurley MM, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N, Nakamura T, Rosen CJ, Doetschman T, Coffin JD 2006 Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochem Biophys Res Commun 341:989-994
8. Naganawa T, Xiao L, Coffin JD, Doetschman T, Sabbieti MG, Agas D, Hurley MM 2008 Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 103:1975-1988
9. Sabbieti MG, Agas D, Xiao L, Marchetti L, Coffin JD, Doetschman T, Hurley MM 2009 Endogenous FGF-2 is critically important in PTH anabolic effects on bone. J Cell Physiol 219:143-151
10. Sobue T, Naganawa T, Xiao L, Okada Y, Tanaka Y, Ito M, Okimoto N, Nakamura T, Coffin JD, Hurley MM 2005 Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. J Cell Biochem 95:83-94
11. Boudreaux JM, Towler DA 1996 Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J Biol Chem 271:7508-7515 (Pubitemid 26107025)
12. Newberry EP, Boudreaux JM, Towler DA 1996 The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif. Mol Endocrinol 10:1029-1040
13. Newberry EP, Latifi T, Towler DA 1999 The RRM domain of MINT, a novel Msx2 binding protein, recognizes and regulates the rat osteocalcin promoter. Biochemistry 38:10678-10690
14. Sierra OL, Cheng SL, Loewy AP, Charlton-Kachigian N, Towler DA 2004 MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element. J Biol Chem 279:32913-32923
15. Willis DM, Loewy AP, Charlton-Kachigian N, Shao JS, Ornitz DM, Towler DA 2002 Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex. J Biol Chem 277:37280-37291
16. Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G 1998 Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ. Mol Cell Biol 18:4197-4208
17. Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y 1998 Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 273:25875-25879
18. Rinaldo C, Siepi F, Prodosmo A, Soddu S 2008 HIPKs: jack of all trades in basic nuclear activities. Biochim Biophys Acta 1783:2124-2129
19. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ 2009 Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem 284:4897-4904
20. Sánchez-Pulido L, Rojas AM, van Wely KH, Martinez-A C, Valencia A 2004 A SPOC: a widely distributed domain associated with cancer, apoptosis and transcription. BMC Bioinformatics 5:91
21. Tsuji M, Shinkura R, Kuroda K, Yabe D, Honjo T 2007 Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling. Proc Natl Acad Sci USA 104:1610-1615
22. Kuroda K, Han H, Tani S, Tanigaki K, Tun T, Furukawa T, Taniguchi Y, Kurooka H, Hamada Y, Toyokuni S, Honjo T 2003 Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 18:301-312
23. Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M, Evans RM 2001 Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev 15:1140-1151
24. Zaidi SK, Javed A, Choi JY, van Wijnen AJ, Stein JL, Lian JB, Stein GS 2001 A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci 114:3093-3102
25. Harrington KS, Javed A, Drissi H, McNeil S, Lian JB, Stein JL, Van Wijnen AJ, Wang YL, Stein GS 2002 Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains. J Cell Sci 115:4167-4176
26. Lu KP, Liou YC, Zhou XZ 2002 Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 12:164-172
27. Sarno S, Pinna LA 2008 Protein kinase CK2 as a druggable target. Mol Biosyst 4:889-894
28. Jensen ED, Gopalakrishnan R, Westendorf JJ 2009 Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2. J Biol Chem 284:2225-2234
29. Hofmann TG, Möller A, Sirma H, Zentgraf H, Taya Y, Dröge W, Will H, Schmitz ML 2002 Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4:1-10
30. Himpel S, Tegge W, Frank R, Leder S, Joost HG, Becker W 2000 Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem 275:2431-2438
31. Jones DC, Wein MN, Oukka M, Hofstaetter JG, Glimcher MJ, Glimcher LH 2006 Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312:1223-1227
32. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL 2003 Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts.Aputative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278:50259-50272
33. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D 2003 E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278:27939-27944
34. Ariyoshi M, Schwabe JW 2003 A conserved structural motif reveals the essential transcriptional repression function of Spen proteins and their role in developmental signaling. Genes Dev 17:1909-1920
35. Choi KY, Kim HJ, Lee MH, Kwon TG, Nah HD, Furuichi T, Komori T, Nam SH, Kim YJ, Kim HJ, Ryoo HM 2005 Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 233:115-121
36. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT 2002 Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187
37. Franceschi RT, Xiao G, Jiang D, Gopalakrishnan R, Yang S, Reith E 2003 Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 44(Suppl 1):109-116
38. Wee HJ, Voon DC, Bae SC, Ito Y 2008 PEBP2-β/CBF-β-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. Blood 112:3777-3787
39. Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML, Koseki H, Kitabayashi I 2006 Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 25:3955-3965
40. Moilanen AM, Karvonen U, Poukka H, Jänne OA, Palvimo JJ 1998 Activation of androgen receptor function by a novel nuclear protein kinase. Mol Biol Cell 9:2527-2543 (Pubitemid 28425892)
41. Lan HC, Li HJ, Lin G, Lai PY, Chung BC 2007 Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain-interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation. Mol Cell Biol 27:2027-2036
42. Nakahara T, Sato H, Shimizu T, Tanaka T, Matsui H, Kawai-Kowase K, Sato M, Iso T, Arai M, Kurabayashi M 2010 Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells. Biochem Biophys Res Commun 394:243-248
43. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimuzu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
44. Wilkie AO, Tang Z, Elanko N, Walsh S, Twigg SR, Hurst JA, Wall SA, Chrzanowska KH, Maxson Jr RE 2000 Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat Genet 24:387-390
45. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R 2000 Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24:391-395
46. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE 1999 Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 205:260-274
47. Cheng SL, Shao JS, Cai J, Sierra OL, Towler DA 2008 Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 283:20505-20522
48. Shao JS, Cheng SL, Sadhu J, Towler DA 2010 Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55:579-592
49. Demer LL, Tintut Y 2008 Vascular calcification: pathobiology of a multifaceted disease. Circulation 117:2938-2948
50. Karsenty G 2008 Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9:183-196
51. Cohen Jr MM 2006 The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A 140:2646-2706
52. Rajamannan NM 2009 Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol 29:162-168
53. Mohler 3rd ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS 2001 Bone formation and inflammation in cardiac valves. Circulation 103:1522-1528 (Pubitemid 32226259)
54. Towler DA, Bennett CD, Rodan GA 1994 Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endocrinol 8:614-624
55. Liu J, Yang H, Liu W, Cao X, Feng X 2005 Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor κB ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem 96:716-727
56. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754 (Pubitemid 27516177)
57. Bae SC, Ogawa E, Maruyama M, Oka H, Satake M, Shigesada K, Jenkins NA, Gilbert DJ, Copeland NG, Ito Y 1994 PEBP2 α B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 14:3242-3252
58. Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M 1995 Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 23:2762-2769
59. Bidder M, Shao JS, Charlton-Kachigian N, Loewy AP, Semenkovich CF, Towler DA 2002 Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J Biol Chem 277: 44485-44496 (Pubitemid 36157883)
60. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA 2003 MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278:45969-45977
61. Hardie DG 2000 Peptide assay of protein kinases and use of variant peptides to determine recognition motifs. In: Walker JM, Keyse SM, eds. Stress response: methods and protocols. Berlin: Springer-Verlag; 191-201